HCAR3 and cancer: Elucidating the potential HCAR3–KYNA axis in cancer may have significant clinical and therapeutic implications, as HCAR3 may represent a new prognostic and predictive biomarker in various cancer types, potentially facilitating personalized treatment strategies.